Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
197.01B | 187.46B | 191.08B | 191.25B | 174.17B | 153.73B | Gross Profit |
49.08B | 46.54B | 42.35B | 40.21B | 41.87B | 38.25B | EBIT |
18.36B | 17.19B | 14.32B | 13.44B | 15.76B | 13.71B | EBITDA |
19.84B | 18.59B | 14.94B | 14.49B | 16.36B | 12.95B | Net Income Common Stockholders |
13.17B | 12.20B | 9.60B | 9.28B | 10.01B | 7.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
46.40B | 48.52B | 41.14B | 24.57B | 31.81B | 23.96B | Total Assets |
125.50B | 120.73B | 102.19B | 95.22B | 87.36B | 77.25B | Total Debt |
11.88B | 14.97B | 10.09B | 12.71B | 9.29B | 10.93B | Net Debt |
-34.52B | -33.55B | -31.05B | -11.85B | -22.52B | -13.03B | Total Liabilities |
40.47B | 41.38B | 33.90B | 35.94B | 35.03B | 33.05B | Stockholders Equity |
84.85B | 79.18B | 67.22B | 58.37B | 51.52B | 43.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.04B | 21.33B | -7.99B | 11.29B | 8.77B | Operating Cash Flow |
0.00 | 8.20B | 24.02B | -6.76B | 13.17B | 10.58B | Investing Cash Flow |
0.00 | -6.20B | -2.74B | -1.19B | -1.52B | -2.02B | Financing Cash Flow |
0.00 | -132.00M | -5.81B | 224.00M | -4.07B | -5.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥131.04B | 9.34 | 3.22% | 10.52% | 15.23% | ||
62 Neutral | $11.81B | 10.34 | -7.44% | 2.91% | 7.41% | -7.93% | |
€1.00B | 14.69 | 10.97% | 2.77% | ― | ― | ||
$567.03M | 17.77 | 15.32% | 3.35% | ― | ― | ||
€955.89M | 4.92 | 30.22% | 1.63% | ― | ― | ||
75 Outperform | ¥107.22B | 14.73 | 2.67% | 8.95% | 4.60% | ||
71 Outperform | ¥88.46B | 20.63 | 5.05% | 0.03% | -23.96% |